Skip to main content
Premium Trial:

Request an Annual Quote

Ah, Genetic Gobbledygook, We Have a Test For That

Britain's Royal College of Pathologists, as well as other scientific associations, is calling for better regulation of at-home testing kits for disease, including genetic disease. They will be telling members of Parliament that companies offering these tests should deposit the data on the product's efficacy in a database so that their claims can be tested and that an official body should be set up to monitor these products. "Companies offering a genuinely valuable service would prosper. Charlatans offering genetic gobbledygook would go to the wall," says Peter Furness, vice president of the Royal College of Pathologists.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.